Dapagliflozin and PAD in HF

23 May 2023 (09:55 - 10:05)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Jawad Haider Butt

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

5 More presentations in this session

Presentation thumbnail

IRONMAN: Effect of intravenous iron according to age

Professor I. Squire (Leicester, GB)

Presentation thumbnail

FINEARTS-HF: Design and Baseline Characteristics

Professor S. Solomon (Boston, US)

Presentation thumbnail

Reasons for hospitalisation and mode of death for patients with heart failure and iron deficiency in the IRONMAN randomized trial.

Professor J. Cleland (Glasgow, GB)

Presentation thumbnail

IRONMAN: anaemia, iron deficiency and quality of life in heart failure and its response to IV iron

Professor P. Kalra (Portsmouth, GB)

Presentation thumbnail

IRONMAN: Which marker of iron deficiency best predicts response to intravenous iron in patients with heart failure?

Professor J. Cleland (Glasgow, GB)

Access the full session

Session thumbnail

Late breaking clinical trials

The Event

Event poster

Heart Failure 2023

23 May 2023 09:55 CET

You may be interested in

Congress Presentation

DAPA-HF & DELIVER: KCCQ across the EF Spectrum

Congress Presentation

Dapagliflozin in patients hospitalised with newly diagnosed heart failure: an analysis of the randomized DAPA ACT HF-TIMI 68 trial

Congress Presentation

Influence of background therapy on efficacy of dapagliflozin in patients with heart failure and improved ejection fraction

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources